Results
GSK India Q2 Revenue Up 21% to ₹1180 Crore
GSK India reported Q2 FY27 revenue of ₹1180 crore, up 21% YoY, with PAT growing 31% to ₹335 crore.
Growth was driven by strong performance in General Medicines, Vaccines, and the newly commercialized
